封面
市場調查報告書
商品編碼
1417530

心臟定位市場報告:2030 年趨勢、預測與競爭分析

Cardiac Mapping Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

心臟定位趨勢與預測

預計到 2030 年,全球心臟定位市場將達到 30 億美元,2024 年至 2030 年複合年成長率為 8.6%。這個市場的主要驅動力是目標疾病數量的增加、老年人口的增加、技術的進步以及投資、資金和津貼的增加。全球心臟定位市場的未來充滿希望,心房顫動、心房撲動和 AVNRT 市場充滿機會。

心臟定位市場洞察

Lucintel 預測,接觸式心臟定位系統將能夠在 3D 環境中進行測繪並準確檢測消融導管部位,久坐的生活方式和日益增加的肥胖將降低兒童和新生兒的心臟病風險。由於比例不斷增加,預計在預測期內將出現高成長。血管疾病。

由於心臟定位系統的臨床試驗核准率不斷提高、測繪系統核准率高以及政府機構頻繁提供研究資助,預計北美在預測期內仍將是最大的地區。

常問問題

Q1.心臟定位的市場規模有多大?

A1. 到 2030 年,全球心臟定位市場預計將達到 30 億美元。

Q2.心臟定位市場的成長預測是多少?

A2. 從 2024 年到 2030 年,全球心臟定位市場預計將以 8.6% 的複合年成長率成長。

Q3. 影響心臟定位市場成長的關鍵促進因素有哪些?

A3. 該市場的主要驅動力是目標疾病數量的增加、老年人口的增加、技術的進步以及投資、資金和津貼的增加。

Q4.心臟定位市場的主要細分市場有哪些?

A4. 全球心臟定位市場的未來看起來充滿希望,心房顫動、心房撲動和 AVNRT 市場有機會。

Q5.心臟定位市場的主要企業有哪些?

A5.主要的心臟定位公司如下。

  • Biosense Webster
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • MicroPort Scientific
  • EP Solutions
  • Acutus Medical
  • Koninklijke Philips
  • Lepu Medical
  • AngioDynamics

Q6. 未來心臟定位市場規模最大的細分市場是哪一個?

A6.Lucintel 預測,接觸式心臟定位系統將能夠在 3D 環境中進行測繪並準確檢測消融導管部位,並且由於久坐的生活方式和兒童的增加,由於血管疾病比例的增加,預計在預測期內會出現高成長。

Q7. 在心臟定位市場中,預計未來五年哪個地區的市場規模最大?

A7. 由於心臟定位系統的臨床試驗核准率較高、測繪系統核准率較高以及政府機構提供研究資助的頻率較高,北美在預測期內將繼續成為最大的地區。

Q.8 是否可以客製化報告?

A8. 是的,Lucintel 提供 10% 的客製化服務,無需額外付費。

目錄

第1章執行摘要

第2章全球心臟定位市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球心臟定位市場趨勢(2018-2023)與預測(2024-2030)
  • 按產品分類的全球心臟定位市場
    • 關於心臟定位系統的詢問
    • 非接觸式心臟定位系統
  • 按適應症分類的全球心臟定位市場
    • 心房顫動
    • 心房撲動
    • AVNRT
    • 其他

第4章 2018-2030年市場趨勢及預測分析:分地區

  • 按地區分類的全球心臟定位市場
  • 北美心臟定位市場
  • 歐洲心臟定位市場
  • 亞太心臟定位市場
  • 其他地區心臟定位市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品分類的全球心臟定位市場成長機會
    • 按適應症分類的全球心臟定位市場成長機會
    • 按地區分類的全球心臟定位市場成長機會
  • 全球心臟定位市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球心臟定位市場的產能擴張
    • 全球心臟定位市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Biosense Webster
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • MicroPort Scientific
  • EP Solutions
  • Acutus Medical
  • Koninklijke Philips
  • Lepu Medical
  • AngioDynamics
簡介目錄

Cardiac Mapping Trends and Forecast

The future of the global cardiac mapping market looks promising with opportunities in the atrial fibrillation, atrial flutter, and AVNRT markets. The global cardiac mapping market is expected to reach an estimated $3.0 billion by 2030 with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are growing number of target illnesses, increase in the number of elderly people, along with the technology progress and an increase in investments, funds, and grants.

A more than 150-page report is developed to help in your business decisions.

Cardiac Mapping by Segment

The study includes a forecast for the global cardiac mapping by product, indication, and region.

Cardiac Mapping Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Contact Cardiac Mapping Systems
  • Non-Contact Cardiac Mapping Systems

Cardiac Mapping Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Atrial Fibrillation
  • Atrial Flutter
  • AVNRT
  • Others

Cardiac Mapping Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cardiac Mapping Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac mapping companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac mapping companies profiled in this report include-

  • Biosense Webster
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • MicroPort Scientific
  • EP Solutions
  • Acutus Medical
  • Koninklijke Philips
  • Lepu Medical
  • AngioDynamics

Cardiac Mapping Market Insights

Lucintel forecasts that contact cardiac mapping system is expected to witness the higher growth over the forecast period because it provides mapping in the 3D environment and accurate ablation catheter site detection, as well as, growing rates of cardiovascular illnesses in children and newborns owing to sedentary lifestyles and an increase in obesity.

North America will remain the largest region over the forecast period due to rise in the region's clinical trial approval rate for cardiac mapping systems, approval rate of mapping systems, as well as, high frequency of government agencies providing funding for research.

Features of the Global Cardiac Mapping Market

Market Size Estimates: Cardiac mapping market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac mapping market size by product, indication, and region in terms of value ($B).

Regional Analysis: Cardiac mapping market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, indication, and regions for the cardiac mapping market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac mapping market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cardiac mapping market size?

Answer: The global cardiac mapping market is expected to reach an estimated $3.0 billion by 2030.

Q2. What is the growth forecast for cardiac mapping market?

Answer: The global cardiac mapping market is expected to grow with a CAGR of 8.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cardiac mapping market?

Answer: The major drivers for this market are growing number of target illnesses, increase in the number of elderly people, along with the technology progress and an increase in investments, funds, and grants.

Q4. What are the major segments for cardiac mapping market?

Answer: The future of the global cardiac mapping market looks promising with opportunities in the atrial fibrillation, atrial flutter, and AVNRT markets.

Q5. Who are the key cardiac mapping market companies?

Answer: Some of the key cardiac mapping companies are as follows.

  • Biosense Webster
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • MicroPort Scientific
  • EP Solutions
  • Acutus Medical
  • Koninklijke Philips
  • Lepu Medical
  • AngioDynamics

Q6. Which cardiac mapping market segment will be the largest in future?

Answer: Lucintel forecasts that contact cardiac mapping system is expected to witness the higher growth over the forecast period because it provides mapping in the 3D environment and accurate ablation catheter site detection, as well as, growing rates of cardiovascular illnesses in children and newborns owing to sedentary lifestyles and an increase in obesity.

Q7. In cardiac mapping market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rise in the region's clinical trial approval rate for cardiac mapping systems, approval rate of mapping systems, as well as, high frequency of government agencies providing funding for research.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cardiac mapping market by product (contact cardiac mapping systems and non-contact cardiac mapping systems), indication (atrial fibrillation, atrial flutter, AVNRT, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Mapping Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cardiac Mapping Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cardiac Mapping Market by Product
    • 3.3.1: Contact Cardiac mapping systems
    • 3.3.2: Non-contact Cardiac mapping systems
  • 3.4: Global Cardiac Mapping Market by Indication
    • 3.4.1: Atrial Fibrillation
    • 3.4.2: Atrial Flutter
    • 3.4.3: AVNRT
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cardiac Mapping Market by Region
  • 4.2: North American Cardiac Mapping Market
    • 4.2.2: North American Cardiac Mapping Market by Indication: Atrial Fibrillation, Atrial Flutter, AVNRT, and Others
  • 4.3: European Cardiac Mapping Market
    • 4.3.1: European Cardiac Mapping Market by Product: Contact Cardiac mapping systems and Non-contact Cardiac mapping systems
    • 4.3.2: European Cardiac Mapping Market by Indication: Atrial Fibrillation, Atrial Flutter, AVNRT, and Others
  • 4.4: APAC Cardiac Mapping Market
    • 4.4.1: APAC Cardiac Mapping Market by Product: Contact Cardiac mapping systems and Non-contact Cardiac mapping systems
    • 4.4.2: APAC Cardiac Mapping Market by Indication: Atrial Fibrillation, Atrial Flutter, AVNRT, and Others
  • 4.5: ROW Cardiac Mapping Market
    • 4.5.1: ROW Cardiac Mapping Market by Product: Contact Cardiac mapping systems and Non-contact Cardiac mapping systems
    • 4.5.2: ROW Cardiac Mapping Market by Indication: Atrial Fibrillation, Atrial Flutter, AVNRT, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cardiac Mapping Market by Product
    • 6.1.2: Growth Opportunities for the Global Cardiac Mapping Market by Indication
    • 6.1.3: Growth Opportunities for the Global Cardiac Mapping Market by Region
  • 6.2: Emerging Trends in the Global Cardiac Mapping Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cardiac Mapping Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Mapping Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Biosense Webster
  • 7.2: Abbott
  • 7.3: Boston Scientific Corporation
  • 7.4: Medtronic
  • 7.5: MicroPort Scientific
  • 7.6: EP Solutions
  • 7.7: Acutus Medical
  • 7.8: Koninklijke Philips
  • 7.9: Lepu Medical
  • 7.10: AngioDynamics